Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BDX · against 1,216 other Healthcare companies
Ranked #664 of 1,217 · scores higher than 45% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 40–49, including BDX · Click a bar to see the companies
A mix: stronger revenue growth, but weaker earnings per share growth than most Healthcare peers.
| Metric | BDX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 18.5% | 6.1% | 76% | 33% | |
| Earnings per share growthHigher is better · 682 reported | -37.5% | 9.7% | 14% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 5.7% | 5.8% | 49% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 664 | 1.03T JPY (≈$7.0B) | 45 | 68 | |
| 664 | 33.1B CNY (≈$4.6B) | 45 | 66 | |
| 664 | 133.4B JPY (≈$907M) | 45 | 53 | |
| 664 | 388.2B JPY (≈$2.6B) | 45 | 62 | |
| 664 | 54.0B USD | 45 | 47 | |
| 664 | 2.0B EUR (≈$2.1B) | 45 | 67 | |
| 664 | 89.7B USD | 45 | 50 | |
| 664 | 34.0B USD | 45 | 49 | |
| 676 | 11.4B CNY (≈$1.6B) | 44 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score